The third RET M918T-mutant medullary thyroid cancer patient in whom we detected a gatekeeper V804M mutation at baseline subsequently developed an acquired Y806C mutation in cis (Fig. 3b). Here, RET is linked to medullary thyroid gland carcinoma.